Neisseriaceae
(meningococci, gonococci)
1
NEISSERIA MENINGITIDIS
(MENINGOCOCCI)
• family Neisseriaceae, genus Neisseria, and
species Neisseria meningitidis
• Meningococci are Gram-negative, oval or
spherical cocci, 0.6 – 0.8 μm in size
• typically arranged in pairs
• non-sporeforming non-motile organisms
• multiple pili and fimbriae
• pathogenic meningococci are enveloped
by a polysaccharide capsule
2
Cultivation
• fastidious bacteria!
• can’t grow on basic nutrient media
• they should be cultured on media with
blood, serum or ascitic fluid
• better in atmosphere with 5-10% CO2
(capnophilic bacteria).
• optimum temperature for growth is 36-
37°С. Bacteria can’t grow at 22°C.
• Meningococci are aerobic or facultatively
anaerobic bacteria
• They are catalase and oxidase positive
• poor biochemical activity
3
Antigenic properties
• Based on their capsular polysaccharide antigens, meningococci are classified into at least 13
serogroups, (A, B, C, D, Y, W-135, etc.)
• Groups A,B and C are most important.
• Group A is usually associated with epidemics
• Group C mostly with localized outbreaks
• Group B caused both epidemics and outbreaks
Virulence factors
• Pili
• outer membrane proteins
• polysaccharide capsule
• IgA proteases
• Hyaluronidase and neuraminidase
• endotoxin
4
Resistance
• Meningococci are very delicate organisms being highly susceptible to
heat, dessication, alterations in pH and to disinfectants.
• They are sensitive to penicillin and other antibiotics, but resistance
strains have emerged and become common in many areas.
5
Pathogenesis and Clinical Findings
in Meningococcal Infections
• anthroponotic disease
• occurs worldwide
• Meningococcal carriers are the predominant source of
infection
• Meningococcus is localized primarily in their
nasopharynx
• The infection is transmitted by the air droplet route
6
Several forms of
meningococcal
infection:
• meningococcal carriage,
• meningococcal nasopharyngitis,
• meningitis,
• and meningococcemia (including
fulminant meningococcal sepsis).
• If meningococcal sepsis (meningococcemia)
has abnormally high fatality rate (20-50%
and even more), meningococcal meningitis
develops lower rate of lethality (about 1-5%)
and post-infectious neurological sequelae (in
10-20% of patients).
7
Laboratory Diagnosis
• Nasopharyngeal swabs and blood samples are taken for culture.
• Specimens of cerebrospinal fluid (CSF) and skin petechiac biopsy are taken for microscopy,
culture, and microbial antigen detection.
• Microscopy of gram-stained slides with the samples of centrifuged CSF detects typical gram-
negative bean-shaped diplococci
• Cultivation of clinical specimens is performed in serum, ascitic or blood agar, supplemented with
antibiotics, suppressing gram-positive microflora (vancomycin, amphotericin or ristomycin). After
incubation for 48 h in aerobic atmosphere pure cultures of meningococci can be recovered from
CSF or blood.
8
Treatment and Prophylaxis
• antibiotics are the cornerstone of treatment
• Beta-lactam antibiotics (penicillin G or third-generation
cephalosporins) are the drugs of choice
• Azalides or chloramphenicol can be used in allergic persons
• specific prophylaxis - polysaccharide chemical vaccines
Vaccination is highly effecient in the control of outbreaks and
epidemics of meningococcal infection conferring the protective
immunity at least for 2-3 years. However, vaccination doesn’t affect
carriers.
9
NEISSERIA
GONORRHOEAE
• causative agents of gonorrhoea
• family Neisseriaceae, genus Neisseria, and species
Neisseria gonorrhoeae
• Gonococci are similar with meningococci (about 70% of
genetic similarity).
• gram-negative, bean-shaped diplococci
• non-sporeforming, non-motile. Unlike meningococci,
Neisseria gonorrhoeae is lack of capsule.
• multiple pili and fimbriae
10
Cultivation
• Gonococci are more difficult to grow than
meningococci.
• They are aerobic but may grow
anaerobically also.
• Growth occurs best at a temperature of
35-36c with 5-10% CO2.
• They grow well on chocolate agar.
• Colonies are small, round, translucent,
convex and slightly umbonate, with a finely
granular surface and lobate margins.
11
Antigenic structure, virulence factors
• gonococci are regarded as the bacteria with highest genetic variability
and genetic exchange with other bacterial species
• Bacterial adhesins, including pili
• Opa and Por proteins
• Endotoxin (LOS)
• beta-lactamases
12
Resistance
• The gonococcus is a very delicate organism, readily killed by heat,
drying and antiseptics.
• In cultures, the coccus dies in 3-4 days but survives in slant cultures at
35oC.
13
Pathogenesis and
Clinical Findings in
Gonorrhoea
• Gonococcus is the strictly human
pathogen.
• Gonorrhoea is a typical sexually
transmitted disease
• Unprotected sexual intercourse
results in 50% likelihood of
disease contraction in women
and 30-50% in men.
• Also gonococci produce
gonorrhoeal conjunctivitis in
adults and ophthalmia
neonatorum (or blennorrhoea)
in newborn infants transmitted
by contact route.
14
Laboratory Diagnosis of Gonorrhoea
• Specimens are collected from the discharge of urethra, vagina, vulva,
cervix, rectum or conjunctiva
• Gram-stained smears of secretions show typical gram-negative bean-
shaped cocci within leukocytes
• microbial culture - the collected specimens are inoculated
immediately into serum or ascitic agar. For men the culture is not
necessary in case of positive microscopic examination, but cultures
for women are indispensable.
• immunofluorescent test
• PCR
15
Treatment and Prophylaxis of Gonorrhoea
• cephalosporins (e.g., ceftriaxone) and macrolides/azalides
(azithromycin)
• combination of azithromycin and gentamycin - against multiresistant
gonococcal strains
• For protection of newborns - eye instillations of sulfacetamide
(sulfacyl-sodium) administered immediately after birth
• protected intercourse - for adults
16

Neisseriaceae.pptx

  • 1.
  • 2.
    NEISSERIA MENINGITIDIS (MENINGOCOCCI) • familyNeisseriaceae, genus Neisseria, and species Neisseria meningitidis • Meningococci are Gram-negative, oval or spherical cocci, 0.6 – 0.8 μm in size • typically arranged in pairs • non-sporeforming non-motile organisms • multiple pili and fimbriae • pathogenic meningococci are enveloped by a polysaccharide capsule 2
  • 3.
    Cultivation • fastidious bacteria! •can’t grow on basic nutrient media • they should be cultured on media with blood, serum or ascitic fluid • better in atmosphere with 5-10% CO2 (capnophilic bacteria). • optimum temperature for growth is 36- 37°С. Bacteria can’t grow at 22°C. • Meningococci are aerobic or facultatively anaerobic bacteria • They are catalase and oxidase positive • poor biochemical activity 3
  • 4.
    Antigenic properties • Basedon their capsular polysaccharide antigens, meningococci are classified into at least 13 serogroups, (A, B, C, D, Y, W-135, etc.) • Groups A,B and C are most important. • Group A is usually associated with epidemics • Group C mostly with localized outbreaks • Group B caused both epidemics and outbreaks Virulence factors • Pili • outer membrane proteins • polysaccharide capsule • IgA proteases • Hyaluronidase and neuraminidase • endotoxin 4
  • 5.
    Resistance • Meningococci arevery delicate organisms being highly susceptible to heat, dessication, alterations in pH and to disinfectants. • They are sensitive to penicillin and other antibiotics, but resistance strains have emerged and become common in many areas. 5
  • 6.
    Pathogenesis and ClinicalFindings in Meningococcal Infections • anthroponotic disease • occurs worldwide • Meningococcal carriers are the predominant source of infection • Meningococcus is localized primarily in their nasopharynx • The infection is transmitted by the air droplet route 6
  • 7.
    Several forms of meningococcal infection: •meningococcal carriage, • meningococcal nasopharyngitis, • meningitis, • and meningococcemia (including fulminant meningococcal sepsis). • If meningococcal sepsis (meningococcemia) has abnormally high fatality rate (20-50% and even more), meningococcal meningitis develops lower rate of lethality (about 1-5%) and post-infectious neurological sequelae (in 10-20% of patients). 7
  • 8.
    Laboratory Diagnosis • Nasopharyngealswabs and blood samples are taken for culture. • Specimens of cerebrospinal fluid (CSF) and skin petechiac biopsy are taken for microscopy, culture, and microbial antigen detection. • Microscopy of gram-stained slides with the samples of centrifuged CSF detects typical gram- negative bean-shaped diplococci • Cultivation of clinical specimens is performed in serum, ascitic or blood agar, supplemented with antibiotics, suppressing gram-positive microflora (vancomycin, amphotericin or ristomycin). After incubation for 48 h in aerobic atmosphere pure cultures of meningococci can be recovered from CSF or blood. 8
  • 9.
    Treatment and Prophylaxis •antibiotics are the cornerstone of treatment • Beta-lactam antibiotics (penicillin G or third-generation cephalosporins) are the drugs of choice • Azalides or chloramphenicol can be used in allergic persons • specific prophylaxis - polysaccharide chemical vaccines Vaccination is highly effecient in the control of outbreaks and epidemics of meningococcal infection conferring the protective immunity at least for 2-3 years. However, vaccination doesn’t affect carriers. 9
  • 10.
    NEISSERIA GONORRHOEAE • causative agentsof gonorrhoea • family Neisseriaceae, genus Neisseria, and species Neisseria gonorrhoeae • Gonococci are similar with meningococci (about 70% of genetic similarity). • gram-negative, bean-shaped diplococci • non-sporeforming, non-motile. Unlike meningococci, Neisseria gonorrhoeae is lack of capsule. • multiple pili and fimbriae 10
  • 11.
    Cultivation • Gonococci aremore difficult to grow than meningococci. • They are aerobic but may grow anaerobically also. • Growth occurs best at a temperature of 35-36c with 5-10% CO2. • They grow well on chocolate agar. • Colonies are small, round, translucent, convex and slightly umbonate, with a finely granular surface and lobate margins. 11
  • 12.
    Antigenic structure, virulencefactors • gonococci are regarded as the bacteria with highest genetic variability and genetic exchange with other bacterial species • Bacterial adhesins, including pili • Opa and Por proteins • Endotoxin (LOS) • beta-lactamases 12
  • 13.
    Resistance • The gonococcusis a very delicate organism, readily killed by heat, drying and antiseptics. • In cultures, the coccus dies in 3-4 days but survives in slant cultures at 35oC. 13
  • 14.
    Pathogenesis and Clinical Findingsin Gonorrhoea • Gonococcus is the strictly human pathogen. • Gonorrhoea is a typical sexually transmitted disease • Unprotected sexual intercourse results in 50% likelihood of disease contraction in women and 30-50% in men. • Also gonococci produce gonorrhoeal conjunctivitis in adults and ophthalmia neonatorum (or blennorrhoea) in newborn infants transmitted by contact route. 14
  • 15.
    Laboratory Diagnosis ofGonorrhoea • Specimens are collected from the discharge of urethra, vagina, vulva, cervix, rectum or conjunctiva • Gram-stained smears of secretions show typical gram-negative bean- shaped cocci within leukocytes • microbial culture - the collected specimens are inoculated immediately into serum or ascitic agar. For men the culture is not necessary in case of positive microscopic examination, but cultures for women are indispensable. • immunofluorescent test • PCR 15
  • 16.
    Treatment and Prophylaxisof Gonorrhoea • cephalosporins (e.g., ceftriaxone) and macrolides/azalides (azithromycin) • combination of azithromycin and gentamycin - against multiresistant gonococcal strains • For protection of newborns - eye instillations of sulfacetamide (sulfacyl-sodium) administered immediately after birth • protected intercourse - for adults 16